ESTRO 35 2016 _____________________________________________________________________________________________________ obtained by the new optimized plans confirm that the EIV method can guide optimization and improve plan quality.
Purpose or Objective: Pareto fronts are a powerful mathematical strategy to formalize the trade-off between a given set of mutually contradicting objectives. We use this strategy to determine the optimal block margin and prescription isodose for both optimal target coverage and normal tissue sparing for VMAT treatments in extracranial stereotactic radiotherapy.
Material and Methods:
Three spherical-shaped targets of different dimensions (20cc, 55cc and 101cc) were selected from our clinical database. GTV included macroscopic disease defined on CT. PTV was defined based on internal margin and setup margin. Healthy liver was considered whole liver minus GTV. A single fraction dose of 26 Gy was prescribed (PD= Prescription Dose). VMAT plans were generated with Ergo++ (Elekta) using a 10MV single arc. Pareto fronts based on (i) different MLC block margin around PTV (ranging from +4mm to -2mm with 1 mm step) and (ii) different prescription isodose line (IDS) ranging from 50% to 100% of PD were produced. For each block margin, the greatest IDS fulfilling the two criteria: 95% of PTV volume reached 100% of PD and 90% of PTV reached 99% of PD was considered as that providing the optimal clinical plan for target coverage. The liver mean dose, V7Gy and V12Gy were used together with the PTV coverage (1-V100) to generate the fronts. The ratio of the prescription isodose surface volume to PTV volume (conformity index CI), gradient index (GI= V50/V100), the ratio of normal tissue volume receiving 50% of prescription dose and PTV volume (NTV50/PTV), homogeneity index (HI= D2%/PD) and healthy liver irradiation in terms of mean dose, V7Gy and V12Gy were calculated to compare different plans Results: A total of about 450 plans (150 per lesion) were calculated for all block margins and isodose lines. Pareto fronts generated for one of the lesions are plotted in figure  1a ,b. For all block margins, PTV coverage is deteriorated with the decrease of liver Dmean, V7Gy and V12Gy. The front for 1mm MLC margin is situated below and on the left of the other fronts for all the three different target sizes. Figure  1c,d show the GI plotted against the prescribed isodose lines and the HI index for the optimal clinical plans. In all cases GI shows a U-shaped behavior with minimum values at 1mm for all metrics. The location of these minimal points was found independent of tumor dimensions. Minimal GI values were found at HI values approximately equal to 1.3. Figure 1e and 1c show the CI and the NTV50/PTV versus HI. With 1mm MLC margin the optimal prescription isodose line was found 77-82% for the three different lesions.
Conclusion:
Pareto fronts provide a rigorous strategy to choice clinical optimal plans in SBRT treatments. Our evaluation shows that a 1mm MLC block margin provides the best results with regard healthy liver tissue irradiation and steepness of dose fallout. This choice provided optimal SBRT plans at dose prescription to 77%-82% isodose line for all target dimensions.
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Treatment of extremity soft tissue sarcoma using protonsrobustness of single and matching fields B. Knäusl Purpose or Objective: Extremity soft tissue sarcomas (ESTS) are treated with combined surgery and radiotherapy, involving large volumes of healthy tissue. This increases late toxicity, which has a negative impact on quality of life. Due to the conformal dose distribution of protons a reduction of healthy tissue exposure can be expected. The clinical benefit in preventing long term toxicity can be fully exploited only if the reproducibility and stability of treatment delivery can be guaranteed. The aim of our study was to show the feasibility and robustness of actively scanned proton therapy with single and matched fields.
Material and Methods:
In 8 postoperative ESTS patients CTV was defined as GTV radially expanded by 1.5cm and longitudinally by 4cm. For PTV the CTV was expanded isotropically by 1cm [1] . The dose prescription was 60Gy (RBE) to D50% of the PTV (2Gy (RBE)/fraction). For treatment planning the software Raystation v4.7 (Raysearch Laboratories, Sweden) was used. 4/8 patients with PTVs longer than 18cm (maximal available field length) required field matching. Robust optimization is the method of choice in Raystation when two fields with different isocenters are
